Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands.
Am J Clin Nutr. 2021 Dec 1;114(6):1917-1924. doi: 10.1093/ajcn/nqab285.
Adipose tissue radiodensity may have prognostic importance for colorectal cancer (CRC) survival. Lower radiodensity is indicative of larger adipocytes, while higher radiodensity may represent adipocyte atrophy, inflammation, or edema.
We investigated associations of adipose tissue radiodensity and longitudinal changes in adipose tissue radiodensity with mortality among patients with nonmetastatic CRC.
In 3023 patients with stage I-III CRC, radiodensities of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were quantified from diagnostic computed tomography (CT) images. There were 1775 patients with follow-up images available. Cox proportional hazards models and restricted cubic splines were used to examine associations of at-diagnosis values and of longitudinal changes in VAT and SAT radiodensities with risks of death after adjusting for potential confounders, including body size and comorbidities.
VAT and SAT radiodensities were linearly associated with all-cause mortality: the HRs for death per SD increase were 1.21 (95% CI, 1.11-1.32) for VAT radiodensity and 1.18 (95% CI, 1.11-1.26) for SAT radiodensity. Changes in adipose tissue radiodensity had curvilinear associations with risks of death. The HR for an increase in VAT radiodensity of at least 1 SD was 1.53 (95% CI, 1.23-1.90), while the HR for a decrease of at least 1 SD was nonsignificant at 1.11 (95% CI, 0.84-1.47) compared with maintaining radiodensity within 1 SD of baseline. Similarly, increases (HR, 1.88; 95% CI, 1.48-2.40) but not decreases (HR, 1.20; 95% CI, 0.94-1.54) in SAT radiodensity significantly increased the risk of death compared with no change in radiodensity.
In patients with nonmetastatic CRC, adipose tissue radiodensity is a novel risk factor for total mortality that is independent of BMI and changes in body weight.
脂肪组织密度可能对结直肠癌(CRC)的生存具有预后意义。较低的密度表示较大的脂肪细胞,而较高的密度可能代表脂肪细胞萎缩、炎症或水肿。
我们研究了非转移性 CRC 患者的脂肪组织密度与纵向脂肪组织密度变化与死亡率之间的关系。
在 3023 例 I-III 期 CRC 患者中,通过诊断性 CT 图像定量了内脏脂肪组织(VAT)和皮下脂肪组织(SAT)的密度。有 1775 例患者有随访图像。使用 Cox 比例风险模型和限制立方样条来检查在调整了潜在混杂因素(包括体型和合并症)后,脂肪组织密度的诊断值和 VAT 和 SAT 密度的纵向变化与死亡风险之间的关系。
VAT 和 SAT 密度与全因死亡率呈线性相关:每增加 1 个标准差,死亡风险比(HR)分别为 1.21(95%CI,1.11-1.32)和 1.18(95%CI,1.11-1.26)。脂肪组织密度的变化与死亡风险呈曲线关系。VAT 密度至少增加 1 个标准差的 HR 为 1.53(95%CI,1.23-1.90),而至少减少 1 个标准差的 HR 无统计学意义,为 1.11(95%CI,0.84-1.47),与基线时保持在 1 个标准差内的密度相比。同样,SAT 密度的增加(HR,1.88;95%CI,1.48-2.40)而非减少(HR,1.20;95%CI,0.94-1.54)显著增加了死亡风险,与密度无变化相比。
在非转移性 CRC 患者中,脂肪组织密度是总死亡率的一个新的危险因素,独立于 BMI 和体重变化。